1. Home
  2. ESP vs SGMT Comparison

ESP vs SGMT Comparison

Compare ESP & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Espey Mfg. & Electronics Corp.

ESP

Espey Mfg. & Electronics Corp.

HOLD

Current Price

$57.13

Market Cap

165.6M

Sector

Technology

ML Signal

HOLD

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$7.53

Market Cap

169.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESP
SGMT
Founded
1928
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
165.6M
169.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
ESP
SGMT
Price
$57.13
$7.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$64.00
$26.13
AVG Volume (30 Days)
60.4K
998.3K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
1.50%
N/A
EPS Growth
N/A
N/A
EPS
2.74
N/A
Revenue
$43,950,872.00
$2,000,000.00
Revenue This Year
$10.30
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
$20.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.00
$4.50
52 Week High
$74.77
$10.27

Technical Indicators

Market Signals
Indicator
ESP
SGMT
Relative Strength Index (RSI) 43.08 53.16
Support Level $54.00 $7.04
Resistance Level $61.58 $8.03
Average True Range (ATR) 2.84 0.46
MACD -0.20 -0.06
Stochastic Oscillator 27.12 46.77

Price Performance

Historical Comparison
ESP
SGMT

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: